COMMUNIQUÉS West-GlobeNewswire

New Data from Ongoing TACTI-mel Study in Unresectable or Metastatic Melanoma Presented at the 4th Annual ICI Europe Summit
27/11/2018
SYDNEY, Australia, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), announces new data from its ongoing TACTI-mel Phase I clinical trial is being presented at the [...]
Daré Bioscience, Inc. Announces Enrollment in Thermography Feasibility Study with Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
27/11/2018
Sildenafil Cream, 3.6% has the Potential to Receive the First FDA Approval for Female Sexual Arousal Disorder SAN DIEGO, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc . (NASDAQ: DARE), a leader in clinical- [...]
Avricore Health Signs Letter of Intent to Partner with FoodRocket to Enhance the HealthTab Platform
27/11/2018
VANCOUVER, British Columbia, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“ Avricore Health ”) is pleased to announce that it has signed a letter of intent to review opportunities to collaborate [...]
Cytokinetics Completes Enrollment in FORTITUDE-ALS, Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS
27/11/2018
Clinical Trial Results Expected First Half 2019 SOUTH SAN FRANCISCO, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the completion of patient enrollment in FORTITUDE- [...]
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
27/11/2018
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) reports the following transactions: 1. Details of the person discharging managerial responsibility / person closely associated a) Name Søren Daniel Niegel 2. Reason for the [...]
Rapid Micro Biosystems Announces New Vice President of Global Sales
27/11/2018
LOWELL, Mass., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the appointment of Scott White as Vice [...]
Evogene’s Leading Insect Control Genes Demonstrate Effectiveness Against Insects with Resistance to Current Commercial Solutions
27/11/2018
External laboratory testing proves efficacy of insect control genes in feeding experiments, indicating new Modes-of-Action REHOVOT, Israel, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading [...]
Invivoscribe Submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to Support Daiichi Sankyo Submissions for Quizartinib
27/11/2018
SAN DIEGO, Nov. 27, 2018 (GLOBE NEWSWIRE) -- In support of an ongoing partnership with Daiichi Sankyo, Invivoscribe is pleased to announce submissions of the LeukoStrat ® CDx FLT3 Mutation Assay to both the US FDA and [...]
ASLAN Pharmaceuticals Announces Acceptance of Abstracts on New Varlitinib Data in BTC at ASCO Gastrointestinal Cancers Symposium
27/11/2018
SINGAPORE, Nov. 27, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]
Transactions in relation to share buyback program
27/11/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Aino Health AB (publ): Aino Health signs agreement with leading wholesaler
27/11/2018
27 November 2018 Aino Health has signed an end user agreement providing Aino HealthManager to one of the largest grocery wholesalers in Finland, with over 20 percent of the market share. The agreement encompasses over [...]
Rule 2.9 Announcement
27/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 27 November 2018 [...]
Sandoz receives eighth European Commission approval for a biosimilar with Ziextenzo® (pegfilgrastim)
27/11/2018
Biosimilar Ziextenzo ® (pegfilgrastim), a long-acting version of supportive oncology medicine filgrastim, is now approved for use in all reference medicine indications [1] Ziextenzo is indicated to reduce duration of [...]
Alcon to highlight its vision, strategy and benefits as a standalone company to investors and analysts in New York and London
27/11/2018
Alcon is the global leader in the highly attractive and growing $23 billion eye care devices market Market leading development capabilities and innovation investments Clearly defined near and long-term strategy, focused [...]
Sensorion Announces Completion of Patient Enrollment and Dosing in Seliforant Phase 2a Study
27/11/2018
First results are expected by the end of the year MONTPELLIER, France, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN) , a clinical-stage biopharmaceutical company specializing in the treatment of [...]
Amarin Prices Public Offering of American Depositary Shares
27/11/2018
BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced the pricing of the underwritten public offering of its American Depositary Shares ("ADSs") [...]
FDA Approves Vitrakvi® (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion(1,2)
27/11/2018
First treatment with a tumor-agnostic indication at the time of initial FDA approval 75% overall response rate (ORR) (95% CI, 61%, 85%) [22% complete response (CR) and 53% partial response (PR)] across various solid [...]
Oxford Immunotec to Participate in Two Investor Conferences This Week
26/11/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief [...]
Akorn Receives Product Approval
26/11/2018
LAKE FOREST, Ill., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a new Abbreviated New Drug Application (ANDA) approval from [...]

Pages